Commentary Comment to FDA on Modified Risk Tobacco Product Application The MRTP pathway is critically important toward reducing the toll of smoking on the U.S. population. By Brian Fojtik and Guy Bentley September 12, 2017 Re: Docket No. FDA-2017-D-3001 Modified Risk Tobacco Product (MRTP) for IQOS System, 82 Fed. Reg. 27487 Guy Bentley is director of consumer freedom at Reason Foundation, a nonprofit think tank advancing free minds and free markets. Media Contact